Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-24

FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Suven Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Suven Pharmaceuticals Limited's supplemental application for chloroquine phosphate under ANDA214756. This approval enables the generic chloroquine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine phosphate (Chloroquine phosphate)

Snippet

SUPPL AP for CHLOROQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE)